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Abstract 
Due to the progress in neuro-imaging 
vestibular schwannomas (benign tumors 
rooting from Scwann cells of vestibular 
nerve) witness an increase in incidence in 
the last decade. Despite the advances in 
operating techniques and intraoperative 
technologies used surgery still presents a 
rate of morbidity and mortality. Gamma-
knife became a therapeutic alternative for 
selected cases of vestibular schwannomas. 
However, the results of gamma-knife 
radiosurgery showed an influence on the 
audiograms of the patientstreated with this 
technique. The goal of our study is to assess 
the measure in which gamma-knife 
treatment influences the neuro-otologic 
behavior of these tumors. We study a series 
of the 33 consecutive cases which 
completed a 24 months follow-up after 
gamma-knife treatment. We use a 
neuroimagistic and neuro-otologic protocol 
aproved by our institution. 
24 patients didn’t show a deterioration of 
the audiogram. Among these 11 report an 
unmodified hearing function, while 11 
describe an improvement in hearing (we 
excluded the cases with complete hearing 
loss.  
We manage to show that strictly 
following the patient selection criteria for 
gamma-knife treatment, radiosurgery is a 
safe treatment option for the patients with 
small to medium-sized vestibular 
scwannomas. 
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Introduction 
Analyzing the results of Gamma-knife 
treatment on patients with vestibular 
schwannomas (within a 4 years monitoring 
period) we observed certain changes in 
audiograms. The goal of the present study 
is to have a measure of photonic radiation 
treatment effect on the neuro-otologic 
behavior of these benign tumors.  
Histologically, vestibular schwannomas 
are benign tumors that grow from the 
Schwann cells of the 8th cranian nerve. 
Due to improved neuroimaging the 
incidence of vestibular schwannomas 
within the general population increased. 
However, despite the advances in 
introperatory techniques, surgery still 
carries a risk for morbidity and mortality. 
Depending on tumors characteristics 
vestibular schwannomas can be treated by 
different methods, other than 
neurosurgery. Radiosurgery is one of these 
non-invasive techniques that can be used to 
treat vestibular schwannomas. It uses 
gamma radiation (photons) and is known as 








Materials and Method 
We study a series of the 33 consecutive 
cases which completed a 24 months follow-
up (at 6, 12, and 24 month) after gamma-
knife treatment. We use a neuroimagistic 
and neuro-otologic protocol aproved by our 
institution. 
We used a Leskell 201 with 611C source 
(photonic unit) in the treatment procedure. 
The patients included in the study 
presented bilateral vestibular schwannomas 
with partial or total hearing loss.  
Inclusion criteria were as follows:  
- Increase in overall dimansions of small 
to medium-sized tumors in patients older 
than 65 years of age 
- Increase in overall dimensions 
folowing partial surgical removal, 
independent of patient age 
- Poor general status 
- Patient’s decision to undergo Gamma-
knife treatment following a in-depth 
discusion with his doctor. 
Results 
For all the patients in the follow-up we 
looked exclusively at the neuro-otologic 
results, regardlessof age, sex, or tumor size 
before and after γ-Knife. 
Clinical evaluation of the patients 
outcome at each monitoring session the 
usual questions asked were: “How do you 
feel after the treatment?” and “How is your 
hearing?”. Considering the possibility of 
answer subjectivity we decided for this 
study to use audiogram as a objective 
measure of radiation effect on neuro-
otologic function. 
From the total number of patients, 4 
(10.6%) declaired hearing deterioration, 21 
(55.2%) indicated no change in hearing 
function, while 13 (34.2%) indicated an 
improvement in hearing. 
Subjective perception aside we focus on 
the quantitative differences in audiograms 
from the time of the treatment up to two 
years follow-up. 
We notice that out of a total of 33 
patients modified audiogram was obtained 
in 24 cases. In 15 cases the audiometric 
curve was shifted towards high frequences, 
while in 9 cases the cruve shifted towards 
lower frequencies. At a normal audiogram 
recording (10dB) we measure the curve 
shift ith a 5dB treshold. 
 
TABLE 1 










Details for the patients that didn’t show a significant shift in audiogram 
Patient   T = 0  
(2 KHz) 
 T = 24 m 
  (2 KHz) 
   T = 0 
 (4 KHz) 
T = 24 m 
(4 KHz) 
Change in hearing 
        Α     52     61     66     58 Improvement 
        Β     36     34     20     19 No change 
        C     50     48     60     61 No change 
        D     100     100     100     100 Total loss 
        Ε     50     48     60     61 Improvement 
        F     61     58     63     60 No change 
        G     39     39     28     26 Improvement 
        H     52     50     59     55 No change 









Details for patients with improvements in audiogram 
Patient   T = 0  
(2 KHz) 
 T = 24 m 
  (2 KHz) 
   T = 0 
 (4 KHz) 
T = 24 m 
(4 KHz) 
Change in hearing 
        Α       91       77       100        78 No change 
        Β       72       50        60        48 No change 
        C       52       10        50        42 Improvement 
        D       44       20        40        20 Improvement 
        Ε       72       66        55        58 Improvement 
        F       81       68        92        76 No change 
        G       60       41        60        57 Improvement 
        H       42       16        46        38 Improvement 
        I       48       28        41        27 Improvement 
        J       82       74        59        49 Improvement 
        K       71       64        73        64 No change 
        L       41       30        48        41 Improvement 
        M       83       50        69        60 Improvement 
        N       44       36        42        32 No change 
        O       78       63        50        52 No change 
 
TABLE 4 
Patients with audiogram deterioration 
Patient   T = 0  
(2 KHz) 
 T = 24 m 
  (2 KHz) 
   T = 0 
 (4 KHz) 
T = 24 m 
(4 KHz) 
Change in hearing 
        Α       64       77        58        78 No change 
        Β       54       63        65        74 No change 
        C       41       60        60        70 Deterioration 
        D       66       75        53        70 Deterioration 
        Ε       52       58        50        62 No change 
        F       53       61        60        73 Deterioration  
        G       66       71        58        66 No change 
        H       63       72        60        68 No change 
         I       50       63        48        61 Deterioration 
 
Discussion 
As described by our results only 9 out of 
33 patients that underwent Gamma-knife 
treatment showed changes in audiograms. 
Furthermore, asked how is their perceived 
hearing function after the treatment, 5 
patients responded that it wasn’t affected by 
the radiation therapy (patients with complete 
hearing loss prior to the treatment aside). 
From the 9 patients that didn’t manifest 
a significant change in their audiogram 
during the 24 months following gamma-
knfe treatment, acustic acuity remained 
unchanged in 4 cases (compared to the pre-
treatment acuity), while 3 of them showed 
an improvement in hearing. 
Finally, from the 15 patients that showed 
a significant improvement their audio-
metric diagram (ΔdB> 5, with an interval 
from 6 dB to 42 dB at 2 KHz, and from -3 
dB to 22 dB at 4 kHz, respectivelly), 7 of 
them reported an improvement in hearing 











Figure 1 Patient K.A. Left: Audiogram in 2006 (34 yrs.) proir to γ-Knife,  44 dB at 2 kHz, 41 dB at 4 kHz.  
Right: Audiogram in 2008 (36 yrs) at two years after the treatment, 20 dB at 2 kHz, 20 dB at 4 kHz 
 
 
Figure 2 Reference dose for the final therapeutic plan   
( 12 Gy  = 68 %, Vol= 34,7 mm2 ) 
Conclusions 
From a total of 24 patients that dind’t 
show a significant change in audiograms, 11 
of them report no modifications in hearing, 
while 11 describe an improvement in 
hearing (we disregard the cases with 
complete hearing loss). While these data do 
not show unequivocally that a change in 
audiogram („quantitative gain”) is 
equivalent to a perceived improvement in 
hearing („qualitative gain”) it shows 
however that complying to strict criteria of 
patient selection for  gamma-knife therapy 
makes this therapy a safe one for treating 
small to medium sized vestibular 
schwannomas. This therapy insures  the 
preservation of the existing auditory acuity 
and even a significant improvement in a 
number of cases. 
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